• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeCover StoryJaap Verweij: an intelligent approach to drug

Jaap Verweij: an intelligent approach to drug

Marc Beishon

1 May 2010 Cover Story 0

Number 36

Download pdf article

Jaap Verweij, head of medical oncology and an early-phase trials expert at the Erasmus University Medical Centre in Rotterdam invites you to reappraise the way we are going about improving cancer therapies.

Download full article

  • clinical trials
  • Jaap Verweij
  • RECIST
Previous article
Next article

Related Articles

Drug Watch

PHARE: shining a light for academic research in Europe

Drug Watch 1 May 2006 0
No Picture
Impact Factor

Dropping bars or rising hoops – phase III outcomes of NSCLC

Impact Factor 1 October 2014 0
No Picture
Grandround

Personalised cancer care: where do we stand today?

Grandround 1 July 2013 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy